Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits
Nuritas has raised $42.0M in total funding. The most recent round was Series C. The last funding was announced in December 2024.
Nuritas's investors include European Investment Bank, Enterprise Ireland, SVG Ventures, European Union, Sandbox Industries.
Nuritas is headquartered in Dublin, Ireland.
Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits
Nuritas is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nuritas — Funding & Investors." VCBacked, December 20, 2024, https://www.vcbacked.co/company/nuritas. Accessed July 19, 2026.
VCBacked. (2024). Nuritas — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/nuritas
{{cite web |title=Nuritas — Funding & Investors |url=https://www.vcbacked.co/company/nuritas |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated